{"disease":{"id":"rickets","name":"Rickets","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":7,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"burosumab","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Crysvita","generic_name":"BUROSUMAB","company_name":"Ultragenyx Pharm Inc","drug_phase":"marketed","molecular_target":"FGF23","drug_class":"","quality_score":62,"revenue":"700","mechanism":"Burosumab-twza binds to and inhibits FGF23, restoring renal phosphate reabsorption and increasing 1,25 dihydroxy vitamin D levels."},{"drug_id":"colecalciferol","indication_name":"Vitamin D Dependent Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infuvite Adult","generic_name":"Colecalciferol","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"falecalcitriol","indication_name":"Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hornel","generic_name":"FALECALCITRIOL","company_name":"Taisho Pharmaceutical","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"cholecalciferol","indication_name":"Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin D3","generic_name":"cholecalciferol","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Sterol 26-hydroxylase, mitochondrial","drug_class":"Vitamin C [EPC]","quality_score":27,"revenue":null,"mechanism":null},{"drug_id":"cholecalciferol","indication_name":"Vitamin D Dependent Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin D3","generic_name":"cholecalciferol","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Sterol 26-hydroxylase, mitochondrial","drug_class":"Vitamin C [EPC]","quality_score":27,"revenue":null,"mechanism":null},{"drug_id":"ergocalciferol","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Drisdol","generic_name":"ERGOCALCIFEROL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial","drug_class":"Provitamin D2 Compound [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"ergocalciferol","indication_name":"Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Drisdol","generic_name":"ERGOCALCIFEROL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial","drug_class":"Provitamin D2 Compound [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"ergocalciferol","indication_name":"Vitamin D Dependent Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Drisdol","generic_name":"ERGOCALCIFEROL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial","drug_class":"Provitamin D2 Compound [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dihydrotachysterol","indication_name":"Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dichystrolum","generic_name":"DIHYDROTACHYSTEROL","company_name":"","drug_phase":"phase_2","molecular_target":"Vitamin D3 receptor","drug_class":"dihydrotachysterol","quality_score":0,"revenue":null,"mechanism":"Dichystrolum works by activating the Vitamin D3 receptor to increase calcium levels in the body."},{"drug_id":"calciferol","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Calciferol","company_name":"Department of Medical Services Ministry of Public Health of Thailand","drug_phase":"phase_1","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"calciferol","indication_name":"Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Calciferol","company_name":"Department of Medical Services Ministry of Public Health of Thailand","drug_phase":"phase_1","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"calciferol","indication_name":"Vitamin D Dependent Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Calciferol","company_name":"Department of Medical Services Ministry of Public Health of Thailand","drug_phase":"phase_1","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"burosumab-twza","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CRYSVITA","generic_name":"BUROSUMAB-TWZA","company_name":"KYOWA KIRIN","drug_phase":"marketed","molecular_target":"Fibroblast growth factor 23","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"colecalciferol","indication_name":"Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infuvite Adult","generic_name":"Colecalciferol","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"calcifediol","indication_name":"Rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rayaldee","generic_name":"CALCIFEDIOL","company_name":"","drug_phase":"marketed","molecular_target":"Sterol regulatory element-binding protein 1","drug_class":"calcifediol","quality_score":10,"revenue":null,"mechanism":"Rayaldee works by increasing the levels of active vitamin D in the body."}],"pipeline":[],"offLabel":[],"totalMarketed":15,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT06202027","title":"Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Kyowa Kirin Korea Co., Ltd.","has_results":false},{"nct_id":"NCT05310760","title":"Effectiveness of Vitamin C Supplementation in Treatment of Rickets","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT03758534","title":"Natural History of GACI With or Without ARHR2 or PXE","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Universität Münster","has_results":false},{"nct_id":"NCT00001242","title":"Studies of States With Resistance to Vitamin D and Parathyroid Hormone","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT04184661","title":"Burosumab and 1-25 (OH) Vitamin D on Human Osteoclasts","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03478839","title":"Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT04372446","title":"Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT04752098","title":"A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method","phase":"NA","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06248632","title":"Effect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLH","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03105557","title":"Specturi Device - Feasibility Study","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Capturin Distribution B.V.","has_results":false},{"nct_id":"NCT03233126","title":"A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT05734196","title":"The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT05050669","title":"Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT07473973","title":"ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT04686175","title":"Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT03348644","title":"Milk Products in the Treatment of Hypophosphatemic Rickets","phase":"NA","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03581591","title":"Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Redwood Dermatology Sciences","has_results":false},{"nct_id":"NCT00844740","title":"Calcimimetics in Hypophosphatemic Rickets","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Children's Mercy Hospital Kansas City","has_results":false},{"nct_id":"NCT06385938","title":"Ultrasound Imaging and Quantitative Vibro-Acoustic Assessment of Rickets Under the Age of Ten","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06739980","title":"The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Inozyme Pharma","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}